AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Impact of Muscle Degeneration in Chronic Low Back Pain

Recruitingn/aAges 18 Years - anyAllHospital Israelita Albert Einstein
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Surgical interventions for the removal of intervertebral disc fragments or to enlarge a narrow spine canal are commonly performed worldwide and are considered efficient. Concomitant low back pain is not uncommon among patients with lumbar nerve compression and neurological symptoms. When present, controversy persists in the literature regarding its ideal management. Although neurological symptoms improve after decompressive surgery, the presence of residual chronic low back pain may worsen satisfaction scores and cause functional disability. The hypothesis of the present study is that the presence of atrophy of the paraspinal and trunk muscles predicts chronic low back pain after lumbar neural decompression. If confirmed, this finding will aid in better planning of physical rehabilitation strategies for this group of patients, as well as a clearer prediction regarding surgical treatment

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. adults 18 years of age and older; 2. with symptoms of lumbosacral neural compression (radiculopathy or neurogenic lameness); 3. failed conservative treatment for at least 6 weeks; 4. undergoing surgery for neural decompression (discectomy and / or foraminotomy and / or hemilaminectomy); 5. with complete pre and postoperative medical records in all evaluations. Exclusion Criteria: 1. need for lumbar arthrodesis; 2. deep infection requiring surgical cleaning; 3. patients submitted to joint facet rhizotomy; 4. active rheumatologic disease, including seronegative arthropathies.
๐Ÿ’Š

What it tests

  • Lumbar decompressive surgery
๐Ÿ“

Where

1 site
Hospital Israelita Albert Einstein
Sรฃo Paulo, Brazil
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy